Blocking lactate production in tumor cells or inhibiting the GPR81 receptor, which mediates lactate signaling, disrupts the mTOR/HIF-1α/STAT3 axis, thereby decreasing the glycolytic and immunosuppressive activities of MDSCs 35. This evidence concerns the gene HIF1A and neoplasm.